Omlonti (Omidenepag Isopropyl)

Omlonti (Omidenepag Isopropyl Ophthalmic Solution) 0.002% is a relatively selective prostaglandin E2 (EP2) receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Dosage And Administration

The recommended dosage is one drop in the affected eye(s) once daily in the evening.

• Pigmentation: Omlonti may cause changes in eye pigmentation. Patients should be monitored for any alterations in eye color.
  
• Eyelash Changes: Omlonti may lead to changes in eyelash characteristics, such as increased length, thickness, pigmentation, and number of eyelashes. These changes may be reversible upon discontinuation.
  
• Ocular Inflammation: Patients should be monitored for signs of ocular inflammation. If inflammation occurs, appropriate treatment should be initiated.
  
• Macular Edema: Macular edema, a swelling in the central part of the retina, may occur. Patients should be closely monitored, and treatment should be adjusted if necessary.
  

If you are considering the import of Omlonti (Omidenepag Isopropyl) to India, please be aware that Omlonti can be imported by patients or government hospitals solely in the name of the patients. The following documentation is essential for the successful import of this medication:

Required Documentation for Import:

• A valid prescription from a qualified medical practitioner.
  
• Diagnostic reports of the patient.
  
• Government-issued identification proof for the patient, as recognized by the Government of India.

The order for Omlonti will be confirmed upon the receipt of the following documents:

• A valid prescription from a qualified doctor.
  
• An import permit, if applicable.

Omlonti (Omidenepag Isopropyl)  is classified as a prescription pharmaceutical drug. Consequently, it legally requires a medical prescription to be dispensed. Indian Pharma Network (IPN) specializes in facilitating the import of cancer medicines through named patient supply (NPS), ensuring transparency and authenticity by sourcing from reputable suppliers in the USA, Canada, Europe, and Australia.

Omlonti can be made accessible to patients, doctors, and hospitals in various cities across India, including but not limited to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune. To confirm an order, a valid prescription from a doctor and an import permit will be required.

IPN (Indian Pharma Network) is dedicated to facilitating the supply of Omlonti (prescription medicines) to locations both within India and worldwide, while adhering to relevant legal requirements.

Our commitment lies in assuring quality and timely delivery to meet the healthcare needs of patients and medical professionals across the globe.

Indian Pharma Network is proficient in sourcing Omlonti (Omidenepag Isopropyl) from around the world and ensuring efficient delivery to patients. We provide worldwide access to the best available treatments and expedite prescription dispensing and delivery, with all prescriptions being dispensed and scrutinized by registered pharmacists before dispatching them to the patient’s address, exclusively from New Delhi, India.

 Is omlonti approved by the FDA?

The FDA approval for OMLONTI® was based on data from 12 clinical studies conducted in multiple global Page 2 locations. Notably, a U.S. Phase 3 study confirmed OMLONTI® to be non-inferior to timolol, the standard of care.

What is omidenepag isopropyl used for?

Omidenepag isopropyl ophthalmic is used to treat glaucoma (a condition in which increased pressure in the eye can lead to gradual loss of vision) and ocular hypertension (a condition which causes increased pressure in the eye). Omidenepag isopropyl is in a class of medications called prostaglandin agonists.

What are the side effects of Omlonti?

The most common adverse reactions with incidence ≥ 1% are conjunctival hyperemia, photophobia, vision blurred, dry eye, instillation site pain, eye pain, ocular hyperemia, punctate keratitis, headache, eye irritation, and visual impairment.

How does Omlonti work?

Omlonti (omidenepag isopropyl) is considered a prostaglandin E2 receptor agonist. It’s not exactly known how Omlonti (omidenepag isopropyl) works, but it’s thought to act on the prostaglandin E2 receptor to help drain fluid out of the eye. This might help lower pressure in the eye.